'Gastroenterol' diaporamas de présentation

221 views • 9 slides

195 views • 1 slides

Brookes, S. J. H. et al. (2013) Extrinsic primary afferent signalling in the gut

Table 1 Distribution of endings of extrinsic primary afferents between the three major anatomical pathways to the gut*. Brookes, S. J. H. et al. (2013) Extrinsic primary afferent signalling in the gut Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2013.29.

115 views • 1 slides

Brookes, S. J. H. et al. (2013) Extrinsic primary afferent signalling in the gut

Figure 1 Five morphological types of extrinsic sensory neurons to the gut. Brookes, S. J. H. et al. (2013) Extrinsic primary afferent signalling in the gut Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2013.29.

65 views • 1 slides

140 views • 1 slides

Figure 2 Comparison of side-branch IPMN and main-duct IPMC by MRI and immunohistochemistry

Figure 2 Comparison of side-branch IPMN and main-duct IPMC by MRI and immunohistochemistry. Erkan, M. et al. (2012) The role of stroma in pancreatic cancer: diagnostic and therapeutic implications Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2012.115.

160 views • 1 slides

169 views • 1 slides

346 views • 1 slides

Figure 2 Venous access sites for hepatic vein catheterization

Figure 2 Venous access sites for hepatic vein catheterization. Bosch, J. et al. (2009) The clinical use of HVPG measurements in chronic liver disease Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2009.149.

415 views • 1 slides

Figure 1 Measuring the portal pressure in the normal and cirrhotic liver

Figure 1 Measuring the portal pressure in the normal and cirrhotic liver. Bosch, J. et al. (2009) The clinical use of HVPG measurements in chronic liver disease Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2009.149.

332 views • 1 slides

Figure 3 Soluble factors produced by the ENS regulate IEB functions

160 views • 1 slides

Figure 2 The ENS forms a complex network in close proximity to the IEB

98 views • 1 slides

120 views • 1 slides

Figure 1 Oesophageal manometry

188 views • 1 slides

Figure 6 Supine abdominal radiograph taken after ingestion of 20 radio-opaque markers 5 days previously. Bredenoord, A. J. & Smout, A. J. P. M. (2013) Advances in motility testing—current and novel approaches Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2013.80.

120 views • 1 slides

Aloi, M. et al. (2013) Advances in the medical management of paediatric IBD

178 views • 1 slides

Dabbouseh, N. M. & Jensen, D. M. (2013) Future therapies for chronic hepatitis C

88 views • 1 slides

Table 2 Data for use of immune modifiers in the treatment of severe gut dysmotility syndromes including CIPO related to myenteric ganglionitis. Permission obtained from John Wiley & Sons Inc. De Giorgio, R. & Camilleri, M. Human enteric neuropathies: morphology and molecular pathology.

142 views • 1 slides

Table 1 Clinicopathological features of LPSP and IDCP

Table 1 Clinicopathological features of LPSP and IDCP. Kamisawa, T. et al. (2010) Autoimmune pancreatitis and IgG4-related sclerosing disease Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2010.81.

243 views • 1 slides

Figure 4 The 5‑HT 4 receptor is expressed by virtually all epithelial cells, including enterochromaffin cells, in the mouse colon. Mawe, G. M. & Hoffman, J. M. (2013) Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets

170 views • 1 slides